Tom Lynch (Rob Tannenbaum, Endpoints News)
Tom Lynch moves to restructure Fred Hutch as academia, industry continue to push cell therapy into solid tumors
By the time former Bristol Myers Squibb CSO Tom Lynch stepped in to run the Fred Hutch Cancer Research Center last year, both the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
